Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic...

Area of Science:

• Oncology
• Preclinical Cancer Models
• Translational Research

Background:

• Preclinical cancer models are crucial for evaluating new treatments before human trials.
• Existing pancreatic tumor models have limitations, including variable growth, unpredictable size, and the need for surgical implantation.
• Surgical implantation can lead to inconsistent tumor uptake and inflammatory responses.

Purpose of the Study:

• To develop a reliable and reproducible orthotopic pancreatic tumor model in mice.
• To establish a method for generating pancreatic cancer models without invasive surgical procedures.
• To facilitate the preclinical evaluation of novel pancreatic cancer therapies.

Main Methods:

• Utilizing Pan02, a murine pancreatic adenocarcinoma cell line.
• Intraperitoneal inoculation of Pan02 cells into C57BL/6 mice.
• Time-course tissue analysis to track tumor development and metastasis.

Main Results:

• Intraperitoneal administration of Pan02 cells consistently resulted in pancreatic tumor formation.
• Tumor growth was observed primarily within the pancreas before spreading to other tissues.
• This method successfully generated orthotopic pancreatic and metastatic neoplasms without surgical implantation or matrices.
• The model demonstrated consistent tumor uptake, synchronized development, and predictable outcomes.

Conclusions:

• The Pan02 intraperitoneal injection model provides a reproducible and non-surgical approach to creating orthotopic pancreatic tumors in mice.
• This model effectively mimics human pancreatic cancer progression and metastasis.
• The established model is suitable for accelerating the preclinical assessment of pancreatic cancer treatment candidates.